The Vanderbilt University

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation

First Posted Date
2019-10-31
Last Posted Date
2020-10-08
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
19
Registration Number
NCT04146779
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Central Pain Syndrome in Survivors of Head and Neck Cancer

First Posted Date
2019-10-16
Last Posted Date
2022-09-19
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
32
Registration Number
NCT04128267
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

First Posted Date
2019-08-28
Last Posted Date
2021-05-21
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
11
Registration Number
NCT04073017
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

PCRC-Supported Legacy Intervention in Pediatric Palliative Care

First Posted Date
2019-08-16
Last Posted Date
2023-11-18
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
300
Registration Number
NCT04059393
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Not Applicable
Terminated
Conditions
Malignant Neoplasm
Interventions
Other: Questionnaire administration
First Posted Date
2019-07-26
Last Posted Date
2020-07-24
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
10
Registration Number
NCT04034914
Locations
🇺🇸

Vanderbilt University School of Nursing, Nashville, Tennessee, United States

ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

First Posted Date
2019-07-10
Last Posted Date
2020-07-07
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Registration Number
NCT04013880

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

First Posted Date
2019-05-24
Last Posted Date
2024-10-11
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
31
Registration Number
NCT03962647
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

First Posted Date
2019-05-01
Last Posted Date
2024-11-14
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
900
Registration Number
NCT03932786
Locations
🇺🇸

University of Minnesoa, Minneapolis, Minnesota, United States

🇺🇸

Texas Childeren's Hospital, Houston, Texas, United States

🇺🇸

Washington School of Medicine at St. Louis, Saint Louis, Missouri, United States

and more 8 locations

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

First Posted Date
2019-04-23
Last Posted Date
2022-04-04
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
3
Registration Number
NCT03924245
Locations
🇺🇸

University of Kansas Cancer Center, Kansas City, Kansas, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

First Posted Date
2018-12-05
Last Posted Date
2023-01-23
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
70
Registration Number
NCT03765099
Locations
🇺🇸

Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy